reference/24886962

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24886962

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial
endingPage	22
issn	0030-9982
issueIdentifier	1
pageRange	18-22
publicationName	JPMA. The Journal of the Pakistan Medical Association
startingPage	18
bibliographicCitation	Naseem A, Hussain Y, Ahmad B, Aziz MT, Ahmad M, Hameed H. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients. J Pak Med Assoc. 2011 Jan;61(1):18–22. PMID: 22368896.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4ab350e2b3fe2633b4f95e4b53444b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90c3030a5b3860bab6c538ba7091412d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ff32e5613c94f526d5abc999d6051bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8a5146dc9159bf668a905bb6dca7129 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_329dc1f6b0e7adea431c5d058dc6b116 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c2de8d7216fa3a2f0084b67effa39de
date	201101
identifier	https://pubmed.ncbi.nlm.nih.gov/22368896
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5350 https://portal.issn.org/resource/ISSN/0030-9982
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients
discusses	http://id.nlm.nih.gov/mesh/M0127410 http://id.nlm.nih.gov/mesh/M0029416 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0448397 http://id.nlm.nih.gov/mesh/M0003827 http://id.nlm.nih.gov/mesh/M0021517
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005334Q000188 http://id.nlm.nih.gov/mesh/D009503Q000188 http://id.nlm.nih.gov/mesh/D002511Q000627 http://id.nlm.nih.gov/mesh/D000900Q000627 http://id.nlm.nih.gov/mesh/D001424Q000188 http://id.nlm.nih.gov/mesh/D019818Q000627 http://id.nlm.nih.gov/mesh/D013982Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077723 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009503Q000209 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D005334Q000209 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008223Q000188 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D001424Q000150 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007231
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37768 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5491295 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479537 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16726873 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65359 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280980

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128137676 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136102420 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135739496

Total number of triples: 70.